Page last updated: 2024-08-16

resveratrol and Peripheral Arterial Disease

resveratrol has been researched along with Peripheral Arterial Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Froldi, G; Ragazzi, E	1
Alós, J; Arjumand, J; Härtel, D; Hohl, C; Korosoglou, G; Langhoff, R; Martínez, E; Raut, W; Reimer, P; Riazi, H; Romani, S; Schmidt, A; Waliszewski, M; Yahya, SA	1
Anton, SD; Criqui, MH; de Cabo, R; Ferrucci, L; Gao, Y; Guralnik, JM; Kibbe, MR; Leeuwenburgh, C; Lloyd-Jones, D; McDermott, MM; Polonsky, TS; Stein, JH; Sufit, R; Tian, L; Zhao, L	1
Bališ, P; Bernátová, I; Pecháňová, O; Púzserová, A; Sestáková, N; Slezák, P	1

Reviews

1 review(s) available for resveratrol and Peripheral Arterial Disease

Article	Year
Selected Plant-Derived Polyphenols as Potential Therapeutic Agents for Peripheral Artery Disease: Molecular Mechanisms, Efficacy and Safety. Molecules (Basel, Switzerland), 2022, Oct-21, Volume: 27, Issue:20 Topics: Curcumin; Humans; Hypoglycemic Agents; Lipids; Peripheral Arterial Disease; Polyphenols; Quercetin; Resveratrol	2022

Trials

1 trial(s) available for resveratrol and Peripheral Arterial Disease

Article	Year
Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. JAMA cardiology, 2017, 08-01, Volume: 2, Issue:8 Topics: Aged; Aged, 80 and over; Antioxidants; Double-Blind Method; Female; Humans; Male; Peripheral Arterial Disease; Physical Endurance; Pilot Projects; Resveratrol; Walk Test	2017

Other Studies

2 other study(ies) available for resveratrol and Peripheral Arterial Disease

Article	Year
The Real-World CONSEQUENT ALL COMERS Study: Predictors for Target Lesion Revascularization and Mortality in an Unselected Patient Population. Angiology, 2021, Volume: 72, Issue:8 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Cardiovascular Agents; Cause of Death; Coated Materials, Biocompatible; Europe; Female; Femoral Artery; Humans; Malaysia; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Recurrence; Resveratrol; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Vascular Access Devices; Vascular Patency	2021
Short-term administration of alibernet red wine extract failed to affect blood pressure and to improve endothelial function in young normotensive and spontaneously hypertensive rats. Physiological research, 2013, Volume: 62, Issue:6 Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Male; Peripheral Arterial Disease; Plant Extracts; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes; Treatment Failure; Treatment Outcome; Vascular Resistance; Wine	2013

Article

Year

The Real-World CONSEQUENT ALL COMERS Study: Predictors for Target Lesion Revascularization and Mortality in an Unselected Patient Population.

Angiology, 2021, Volume: 72, Issue:8

Topics: Aged; Aged, 80 and over; Angioplasty, Balloon; Cardiovascular Agents; Cause of Death; Coated Materials, Biocompatible; Europe; Female; Femoral Artery; Humans; Malaysia; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prospective Studies; Recurrence; Resveratrol; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Vascular Access Devices; Vascular Patency

2021

Short-term administration of alibernet red wine extract failed to affect blood pressure and to improve endothelial function in young normotensive and spontaneously hypertensive rats.

Physiological research, 2013, Volume: 62, Issue:6

Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Male; Peripheral Arterial Disease; Plant Extracts; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes; Treatment Failure; Treatment Outcome; Vascular Resistance; Wine

2013